1. Home
  2. GCT vs ANAB Comparison

GCT vs ANAB Comparison

Compare GCT & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCT
  • ANAB
  • Stock Information
  • Founded
  • GCT 2019
  • ANAB 2005
  • Country
  • GCT United States
  • ANAB United States
  • Employees
  • GCT N/A
  • ANAB N/A
  • Industry
  • GCT Catalog/Specialty Distribution
  • ANAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • GCT Consumer Discretionary
  • ANAB Health Care
  • Exchange
  • GCT Nasdaq
  • ANAB Nasdaq
  • Market Cap
  • GCT 734.6M
  • ANAB 759.5M
  • IPO Year
  • GCT 2022
  • ANAB 2017
  • Fundamental
  • Price
  • GCT $19.83
  • ANAB $15.85
  • Analyst Decision
  • GCT Strong Buy
  • ANAB Buy
  • Analyst Count
  • GCT 3
  • ANAB 11
  • Target Price
  • GCT $51.33
  • ANAB $42.67
  • AVG Volume (30 Days)
  • GCT 1.1M
  • ANAB 635.1K
  • Earning Date
  • GCT 03-14-2025
  • ANAB 03-10-2025
  • Dividend Yield
  • GCT N/A
  • ANAB N/A
  • EPS Growth
  • GCT 107.06
  • ANAB N/A
  • EPS
  • GCT 3.17
  • ANAB N/A
  • Revenue
  • GCT $1,109,997,000.00
  • ANAB $57,172,000.00
  • Revenue This Year
  • GCT $58.56
  • ANAB $229.13
  • Revenue Next Year
  • GCT $19.00
  • ANAB N/A
  • P/E Ratio
  • GCT $6.26
  • ANAB N/A
  • Revenue Growth
  • GCT 89.84
  • ANAB 282.17
  • 52 Week Low
  • GCT $15.61
  • ANAB $12.51
  • 52 Week High
  • GCT $45.18
  • ANAB $41.31
  • Technical
  • Relative Strength Index (RSI)
  • GCT 49.38
  • ANAB 48.16
  • Support Level
  • GCT $19.50
  • ANAB $14.76
  • Resistance Level
  • GCT $20.49
  • ANAB $15.63
  • Average True Range (ATR)
  • GCT 1.03
  • ANAB 0.99
  • MACD
  • GCT 0.26
  • ANAB 0.53
  • Stochastic Oscillator
  • GCT 59.41
  • ANAB 89.66

About GCT GigaCloud Technology Inc

GigaCloud Technology Inc end-to-end B2B e-commerce solutions for large parcel merchandise. Its B2B e-commerce platform, which is referred to as the GigaCloud Marketplace, integrates everything from discovery, payments, and logistics tools into one easy-to-use platform. It offers online and offline integrated cross-border transaction and delivery services for furniture and large merchandise. Its marketplace seamlessly connects manufacturers in Asia, with resellers in the U.S., Asia, and Europe, to execute cross-border transactions with confidence, speed, and efficiency. It offers a truly comprehensive solution that transports products from the manufacturer's warehouse to end customers, all at one fixed price.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, our PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, our BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: